Showing results (31-40 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|August 13, 2002
Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatmentThomas Rau, Roland Heide, Klaus Bergmann, et al.Pharmacogenetics|May 8, 2001
Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brainI Siegle, P Fritz, K Eckhardt, et al.Pharmacogenetics|October 23, 2001
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6U M Zanger, J Fischer, S Raimundo, et al.Pharmacogenetics|October 23, 2001
Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivoY Caraco, M Muszkat, A J WoodPharmacogenetics|October 23, 2001
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptivesI B Runnebaum, S Wang-Gohrke, D Vesprini, et al.Pharmacogenetics|May 2, 2003
NAT2 slow acetylator function as a risk indicator for age-related cataract formationDavid Meyer, Donald P Parkin, Heine I Seifart, et al.Pharmacogenetics|August 2, 2003
Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphismHans Hauner, Marion Meier, Karl-Heinz Jöckel, et al.Pharmacogenetics|August 2, 2003
Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samplesJames M Rae, Kevin E Cordero, Joshua O Scheys, et al.Pharmacogenetics|August 2, 2003
Mutations in mitochondrial aldehyde dehydrogenase (ALDH2) change cofactor affinity and segregate with voluntary alcohol consumption in ratsA Sapag, L Tampier, A Valle-Prieto, et al.Pharmacogenetics|September 16, 2003
An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulationKersten M Small, Kari M Brown, Cheryl T Theiss, et al.Pageof 83